Estadístiques de Pharmacogenomic study in patients with multiple sclerosis Responders and nonresponders to IFN-β
Visites totals
| views | |
|---|---|
| Pharmacogenomic study in patients with multiple sclerosis Responders and nonresponders to IFN-β | 154 |
Visites totals per mes
| views | |
|---|---|
| May 2025 | 0 |
| June 2025 | 0 |
| July 2025 | 0 |
| August 2025 | 0 |
| September 2025 | 0 |
| October 2025 | 0 |
| November 2025 | 0 |
Visites al fitxer
| views | |
|---|---|
| Navarro_Neurol_Phar.pdf(legacy) | 183 |
| Navarro_Neurol_Phar.pdf | 96 |
Vistes principals per país
| views | |
|---|---|
| United States | 107 |
| Ireland | 13 |
| Germany | 9 |
| Spain | 9 |
| Czechia | 4 |
| France | 4 |
| Belgium | 2 |
| Australia | 1 |
| China | 1 |
| Malaysia | 1 |
| Sweden | 1 |
| Slovenia | 1 |
Visites principals per ciutat
| views | |
|---|---|
| Ashburn | 22 |
| Fairfield | 15 |
| San Ramon | 14 |
| Dublin | 12 |
| Barcelona | 9 |
| Cambridge | 7 |
| San Diego | 7 |
| Menlo Park | 6 |
| Hérouville-saint-clair | 4 |
| Mountain View | 3 |
| Seattle | 3 |
| Ann Arbor | 2 |
| Boardman | 2 |
| San Mateo | 2 |
| Cupertino | 1 |
| Magdeburg | 1 |
| Petaling Jaya | 1 |
| Phoenix | 1 |
| Shenzhen | 1 |
| Stockholm | 1 |
| Tustin | 1 |